• Je něco špatně v tomto záznamu ?

Prevalence of underweight, overweight, and obesity in children and adolescents with type 1 diabetes: Data from the international SWEET registry

C. Maffeis, NH. Birkebaek, M. Konstantinova, A. Schwandt, A. Vazeou, K. Casteels, S. Jali, C. Limbert, A. Pundziute-Lycka, P. Toth-Heyn, C. de Beaufort, Z. Sumnik, V. Cherubini, J. Svensson, D. Pacaud, C. Kanaka-Gantenbein, S. Shalitin, N....

. 2018 ; 19 (7) : 1211-1220. [pub] 20180822

Jazyk angličtina Země Dánsko

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc19028312

OBJECTIVE: To assess the prevalence of underweight (UW), overweight (OW), and obesity in children and adolescents with type 1 diabetes (T1D). METHODS: An international cross-sectional study including 23 026 T1D children (2-18 years, duration of diabetes ≥1 year) participating in the SWEET prospective, multicenter diabetes registry. Body mass index SD score (BMI-SDS) was calculated using the World Health Organization BMI charts. Children were categorized as UW (BMI-SDS < -2SD), OW (+1SD < BMI-SDS ≤ +2SD), and obese (OB) (BMI-SDS > +2SD). Hierarchic regression models were applied with adjustment for sex, age, and duration of diabetes. RESULTS: The prevalence of UW, OW, and obesity was: 1.4%, 22.3%, and 7.3% in males and 0.6%, 27.2%, and 6.8% in females. Adjusted BMI-SDS was significantly higher in females than in males (mean ± SEM: 0.54 ± 0.05 vs 0.40 ± 0.05, P < 0.0001). In males, BMI-SDS significantly decreased by age (P < 0.0001) in the first three age categories 0.61 ± 0.06 (2 to <10 years), 0.47 ± 0.06 (10 to <13 years), 0.34 ± 0.05 (13 to <16 years). In females, BMI-SDS showed a U-shaped distribution by age (P < 0.0001): 0.54 ± 0.04 (2 to <10 years), 0.39 ± 0.04 (10 to <13 years), 0.55 ± 0.04 (13 to <16 years). BMI-SDS increased by diabetes duration (<2 years: 0.38 ± 0.05, 2 to <5 years: 0.44 ± 0.05, and ≥5 years: 0.50 ± 0.05, P < 0.0001). Treatment modality did not affect BMI-SDS. Adjusted HbA1c was significantly higher in females than in males (8.20% ± 0.10% vs 8.06% ± 0.10%, P < 0.0001). In both genders, the association between HbA1c and BMI-SDS was U-shaped with the highest HbA1c in the UW and obesity groups. CONCLUSIONS: The high rate of OW and obesity (31.8%) emphasize the need for developing further strategies to prevent and treat excess fat accumulation in T1D.

1st Department of Pediatrics Semmelweis University Budapest Hungary

Alberta Children's Hospital Research Institute University of Calgary Calgary Alberta Canada

APDP Diabetes Portugal Department of Pediatric and adolescents Lisbon Portugal

Barbara Davis Center University of Colorado Aurora Colorado

Clinic for Endocrinology Diabetes and Genetics Medical University Sofia University Pediatric Hospital Sofia Bulgaria

Deccp Pediatric Clinic Centre Hospitalier de Luxembourg Luxembourg Grand Duche de Luxembourg

Department of Pediatric and adolescents Copenhagen University hospital Herlev Denmark

Department of Pediatrics Aarhus University Hospital Aarhus Denmark

Department of Pediatrics Motol University Hospital Prague Czech Republic

Department of Pediatrics University Hospitals Leuven Leuven Belgium Department of Development and Regeneration University of Leuven Leuven Belgium

Department of Women's and Children Health Salesi Hospital Ancona Italy

Diabetes Center 1st Department of Pediatrics Medical School National and Kapodistrian University of Athens Agia Sophia Children's Hospital Athens Greece

Diabetes Center P and A Kyriakou Children's Hospital Athens Greece

General Private Practitioner at T1diams Mauritius Island

Hospital Dona Estefânia Unit of Pediatric Endocrinology and Diabetes Lisbon Portugal

Institute of Epidemiology and Medical Biometry ZIBMT University of Ulm Ulm Germany German Center for Diabetes Research Munich Neuherberg Germany

KLE Diabetes Centre KLE University JNMC and KLE'S Dr Prabhakar Kore Hospital and MRC Belagavi India

Pediatric Diabetes and Metabolic Disorders Unit University of Verona University City Hospital Verona Italy

Queen Silvia Children's Hospital Sahlgrenska University Hospital Gothenburg Sweden

The Jesse Z and Lea Shafer Institute of Endocrinology and Diabetes Schneider Children's Medical Center of Israel Petach Tikva Israel Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel

The Sahlgrenska Academy University of Gothenburg Gothenburg Sweden and NU Hospital Group Uddevalla Sweden

University Children's Hospital Department of Endocrinology Diabetes and Metabolic Diseases Ljubljana Slovenia

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028312
003      
CZ-PrNML
005      
20210907091918.0
007      
ta
008      
190813s2018 dk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/pedi.12730 $2 doi
035    __
$a (PubMed)30033651
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a dk
100    1_
$a Maffeis, Claudio $u Pediatric Diabetes and Metabolic Disorders Unit, University of Verona, University City Hospital, Verona, Italy.
245    10
$a Prevalence of underweight, overweight, and obesity in children and adolescents with type 1 diabetes: Data from the international SWEET registry / $c C. Maffeis, NH. Birkebaek, M. Konstantinova, A. Schwandt, A. Vazeou, K. Casteels, S. Jali, C. Limbert, A. Pundziute-Lycka, P. Toth-Heyn, C. de Beaufort, Z. Sumnik, V. Cherubini, J. Svensson, D. Pacaud, C. Kanaka-Gantenbein, S. Shalitin, N. Bratina, R. Hanas, GT. Alonso, L. Poran, AL. Pereira, M. Marigliano, SWEET Study Group,
520    9_
$a OBJECTIVE: To assess the prevalence of underweight (UW), overweight (OW), and obesity in children and adolescents with type 1 diabetes (T1D). METHODS: An international cross-sectional study including 23 026 T1D children (2-18 years, duration of diabetes ≥1 year) participating in the SWEET prospective, multicenter diabetes registry. Body mass index SD score (BMI-SDS) was calculated using the World Health Organization BMI charts. Children were categorized as UW (BMI-SDS < -2SD), OW (+1SD < BMI-SDS ≤ +2SD), and obese (OB) (BMI-SDS > +2SD). Hierarchic regression models were applied with adjustment for sex, age, and duration of diabetes. RESULTS: The prevalence of UW, OW, and obesity was: 1.4%, 22.3%, and 7.3% in males and 0.6%, 27.2%, and 6.8% in females. Adjusted BMI-SDS was significantly higher in females than in males (mean ± SEM: 0.54 ± 0.05 vs 0.40 ± 0.05, P < 0.0001). In males, BMI-SDS significantly decreased by age (P < 0.0001) in the first three age categories 0.61 ± 0.06 (2 to <10 years), 0.47 ± 0.06 (10 to <13 years), 0.34 ± 0.05 (13 to <16 years). In females, BMI-SDS showed a U-shaped distribution by age (P < 0.0001): 0.54 ± 0.04 (2 to <10 years), 0.39 ± 0.04 (10 to <13 years), 0.55 ± 0.04 (13 to <16 years). BMI-SDS increased by diabetes duration (<2 years: 0.38 ± 0.05, 2 to <5 years: 0.44 ± 0.05, and ≥5 years: 0.50 ± 0.05, P < 0.0001). Treatment modality did not affect BMI-SDS. Adjusted HbA1c was significantly higher in females than in males (8.20% ± 0.10% vs 8.06% ± 0.10%, P < 0.0001). In both genders, the association between HbA1c and BMI-SDS was U-shaped with the highest HbA1c in the UW and obesity groups. CONCLUSIONS: The high rate of OW and obesity (31.8%) emphasize the need for developing further strategies to prevent and treat excess fat accumulation in T1D.
650    _2
$a mladiství $7 D000293
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a průřezové studie $7 D003430
650    _2
$a diabetes mellitus 1. typu $x komplikace $x epidemiologie $7 D003922
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a obezita $x komplikace $x epidemiologie $7 D009765
650    _2
$a prevalence $7 D015995
650    12
$a registrace $7 D012042
650    _2
$a hubenost $x epidemiologie $7 D013851
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Birkebaek, Niels H $u Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark.
700    1_
$a Konstantinova, Maia $u Clinic for Endocrinology, Diabetes and Genetics, Medical University Sofia, University Pediatric Hospital, Sofia, Bulgaria.
700    1_
$a Schwandt, Anke $u Institute of Epidemiology and Medical Biometry, ZIBMT, University of Ulm, Ulm, Germany. German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany.
700    1_
$a Vazeou, Andriani $u Diabetes Center, P & A Kyriakou Children's Hospital, Athens, Greece.
700    1_
$a Casteels, Kristina $u Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium. Department of Development and Regeneration, University of Leuven, Leuven, Belgium.
700    1_
$a Jali, Sujata $u KLE Diabetes Centre, KLE University JNMC and KLE'S Dr. Prabhakar Kore Hospital & MRC, Belagavi, India.
700    1_
$a Limbert, Catarina $u Hospital Dona Estefânia, Unit of Pediatric Endocrinology and Diabetes, Lisbon, Portugal.
700    1_
$a Pundziute-Lycka, Auste $u Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.
700    1_
$a Toth-Heyn, Peter $u Ist. Department of Pediatrics, Semmelweis University, Budapest, Hungary.
700    1_
$a de Beaufort, Carine $u Deccp, Pediatric Clinic/Centre Hospitalier de Luxembourg, Luxembourg, Grand Duche de Luxembourg.
700    1_
$a Sumnik, Zdenek $u Department of Pediatrics, Motol University Hospital, Prague, Czech Republic.
700    1_
$a Cherubini, Valentino $u Department of Women's and Children Health, Salesi Hospital, Ancona, Italy.
700    1_
$a Svensson, Jannet $u Department of Pediatric and adolescents, Copenhagen University hospital, Herlev, Denmark.
700    1_
$a Pacaud, Daniele $u Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada.
700    1_
$a Kanaka-Gantenbein, Christina $u Diabetes Center, First Department of Pediatrics, Medical School,National and Kapodistrian University of Athens, Agia Sophia Children's Hospital, Athens, Greece.
700    1_
$a Shalitin, Shlomit $u The Jesse Z. and Lea Shafer Institute of Endocrinology and Diabetes, Schneider Children's Medical Center of Israel, Petach Tikva, Israel. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
700    1_
$a Bratina, Natasa $u University Children's Hospital, Department of Endocrinology, Diabetes and Metabolic Diseases, Ljubljana, Slovenia.
700    1_
$a Hanås, Ragnar, $u The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden and NU Hospital Group, Uddevalla, Sweden. $d 1951- $7 xx0263839
700    1_
$a Alonso, Guy T $u Barbara Davis Center, University of Colorado, Aurora, Colorado.
700    1_
$a Poran, Luxmi $u General Private Practitioner at T1diams, Mauritius, Island.
700    1_
$a Pereira, Ana L $u APDP-Diabetes Portugal, Department of Pediatric and adolescents, Lisbon, Portugal.
700    1_
$a Marigliano, Marco $u Pediatric Diabetes and Metabolic Disorders Unit, University of Verona, University City Hospital, Verona, Italy.
710    2_
$a SWEET Study Group
773    0_
$w MED00181048 $t Pediatric diabetes $x 1399-5448 $g Roč. 19, č. 7 (2018), s. 1211-1220
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30033651 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20210907091914 $b ABA008
999    __
$a ok $b bmc $g 1433461 $s 1066772
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 19 $c 7 $d 1211-1220 $e 20180822 $i 1399-5448 $m Pediatric diabetes $n Pediatr Diabetes $x MED00181048
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Možnosti archivace